Trending Now
LATEST ARTICLES
The Drug Is Ready. The Test Isn’t. Who Owns the Launch Failure?
Precision medicine promises the right treatment for the right patient. But what happens when the drug is ready and the test needed to identify...
Your Drug Is Decaying on the Way to the Patient. Welcome to Radiopharma Marketing.
Imagine launching a cancer treatment that begins losing radioactive strength before reaching the patient. For pharmaceutical marketers, that challenge is becoming a commercial reality....
Cancer Support Is Usually Treated Like an Extra. This Campaign Says It’s Part of...
Cancer treatment is often defined by chemotherapy, surgery, radiation, and medication. But what about the emotional, financial, and practical challenges patients face along the...
Vitiligo Is Visible. AbbVie Is Marketing What Patients Can’t See.
Vitiligo is visible, but its emotional consequences often are not. AbbVie’s Look Deeper than Pigment campaign shows how hidden disease burden marketing can bring...
Ninety-Three Studies Reopened Pharma’s Oldest Marketing Question: How Much Influence Is Too Much?
A new Cochrane review has reopened one of pharmaceutical marketing's most uncomfortable questions: when does professional engagement become undue influence? Examining 93 studies, researchers...
Kidney Patients Aren’t Just an Audience Anymore. They’re Becoming a Constituency.
For years, pharmaceutical companies have approached patient advocacy through education campaigns, disease awareness programs, and partnerships with patient organizations. However, the American Association of...
What If Patient Ambassadors Were Your Best Research Team?
What if your most valuable research team already understood your patients because they were patients themselves? Could a patient ambassador strategy built around continuous...
A Prescription Wearable Went on TV. The Funnel Looks Nothing Like Pharma’s Usual One.
The way prescription medical devices reach consumers is changing, and Osteoboost's national television campaign offers a revealing example of that shift. In September 2026,...
“I’ll Start Therapy When Life Calms Down.” Rula Tried to Remove the Excuse.
People often know they need mental health support. However, knowing and acting are two different things. Between work, family responsibilities, and endless household chores,...
The Campaign Wasn’t the Only Risk. The Governance Broke Down Too.
When it comes to pharma marketing governance, companies often focus on what the public sees: advertisements, claims, sponsorship messages, and promotional content. However, some...






















